LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alzheimer's Risk Genes Linked to Brain Atrophy

By LabMedica International staff writers
Posted on 10 Jan 2016
Print article
The single nucleotide polymorphism (SNP) Human Omni-Quad array
The single nucleotide polymorphism (SNP) Human Omni-Quad array (Photo courtesy of Illumina)
Two genetic variants previously linked to Alzheimer's disease (AD) have been more specifically tied to brain atrophy that is characteristic of the disease.

A direct link has been found of common variants of two genes to atrophy in cortical and hippocampal regions of the brain, which are associated with memory and other key functions. It is also believed to be the first to link the atrophy to protein levels in the blood produced by the genes.

Neurobiologists at the Indiana University School of Medicine (Indianopolis, IN, USA) and their colleagues conducted a study in 50 participants with no cognitive difficulties and 90 who had been diagnosed with mild cognitive impairment, a condition that is associated with increased risk of developing Alzheimer's disease. All of the participants were 50 years or older. The team investigated the top nine genetic variants that have been associated with Alzheimer's disease risk, not including the apolipoprotein E (APOe4) gene that has long been linked to increased risk for several characteristics of Alzheimer's disease.

The team used magnetic resonance imaging tools to measure brain size and genetic analysis, the scientists looked for associations between the genetic variants and atrophy in the cortical and hippocampal regions of the brain, which are established physical biomarkers of Alzheimer's disease. Peripheral blood expression array data was obtained using the 1-million SNP Illumina Human Omni-Quad array and Illumina Human BeadChips (Illumina; San Diego, CA, USA). After explicit matching of cortical and hippocampal morphology they computed in 3D the cortical thickness and hippocampal radial distance measures for each participant.

The scientists found that just two genetic variants of the Membrane-Spanning 4-Domains, Subfamily A, Member 6A (MS4A6A rs610932) and the ATP-Binding Cassette, Sub-Family A (ABC1), Member 7 (ABCA7 rs3764650) were significantly associated with cortical and hippocampal atrophy. Exploratory MS4A6A and ABCA7 peripheral blood expression analyses revealed a similar pattern of associations with cortical neurodegeneration.

Liana G. Apostolova, MD, the Barbara and Peer Baekgaard, professor of Alzheimer's Disease Research and senior author of the study said, “We also found that the levels of the protein products of these genes, circulating in the peripheral blood, were associated with the cortical and hippocampal atrophy. This finding suggests that those results of gene expression could become useful biomarker blood tests for Alzheimer's disease.” The study was published online on November 05, 2015, in the journal Neurobiology of Aging.

Related Links:

Indiana University School of Medicine 
Illumina  


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more